Compare VanEck Australian Floating Rate ETF (FLOT) vs GSK plc (GSK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
VanEck Australian Floating Rate ETF vs GSK plc — how do they compare? VanEck Australian Floating Rate ETF trades at $50.98, while GSK plc trades at $52.4 (market cap $101.34B). The key difference: GSK plc pays a 3.49% dividend while VanEck Australian Floating Rate ETF pays none. Which is the better fit depends on your goals.
| FLOT | GSK | |
|---|---|---|
Sector | Sector/Thematic | Health |
52-Week High | $51.09 | $61.18 |
52-Week Low | $50.72 | $36.20 |
Market Cap | — | $101.34B |
Enterprise Value | — | $121.95B |
Dividend Yield | — | 3.49% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About VanEck Australian Floating Rate ETF
FLOT provides exposure to a diversified portfolio of Australian dollar-denominated floating rate notes. It tracks the Bloomberg AusBond Credit FRN 0+ Yr Index, focusing on high-quality, investment-grade bonds from top Australian banks and financial institutions.
Read more on FLOT →About GSK plc
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, cancer, and antiviral, as well as vaccines. GSK uses joint ventures to gain additional scale in certain markets like HIV.
Read more on GSK →
